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ABSTRACT 
 
Musculoskeletal infections are infections of the bone and surrounding 
tissues.  They are currently diagnosed based on culture analysis, which is the gold 
standard for pathogen identification. However, these clinical laboratory methods are 
frequently inadequate for the identification of the causative agents, because a large 
percentage (25-50%) of confirmed musculoskeletal infections are false negatives in 
which no pathogen is identified in culture. My data supports these results. The goal 
of this project was to use PCR amplification of a portion of the 16S rRNA gene to 
test an alternative approach for the identification of these pathogens and to assess 
the diversity of the bacteria involved. The advantages of this alternative method are 
that it should increase sample sensitivity and the speed of detection. In addition, 
bacteria that are non-culturable or in low abundance can be detected using this 
molecular technique. However, a complication of this approach is that the majority 
of musculoskeletal infections are polymicrobial, which prohibits direct identification 
from the infected tissue by DNA sequencing of the initial 16S rDNA amplification 
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products. One way to solve this problem is to use denaturing gradient gel 
electrophoresis (DGGE) to separate the PCR products before DNA sequencing. 
 Denaturing gradient gel electrophoresis (DGGE) separates DNA molecules 
based on their melting point, which is determined by their DNA sequence. This 
analytical technique allows a mixture of PCR products of the same length that 
electrophoreses through agarose gels as one band, to be separated into different 
bands and then used for DNA sequence analysis.  In this way, the DGGE allows for 
the identification of individual bacterial species in polymicrobial-infected tissue, 
which is critical for improving clinical outcomes. By combining the 16S rDNA 
amplification and the DGGE techniques together, an alternative approach for 
identification has been used.  
The 16S rRNA gene PCR-DGGE method includes several critical steps: DNA 
extraction from tissue biopsies, amplification of the bacterial DNA, PCR product 
separation by DGGE, amplification of the gel-extracted DNA, and DNA sequencing 
and analysis. Each step of the method was optimized to increase its sensitivity and 
for rapid detection of the bacteria present in human tissue samples. The limit of 
detection for the DNA extraction from tissue was at least 20 Staphylococcus aureus 
cells and the limit of detection for PCR was at least 0.05 pg of template DNA. The 
conditions for DGGE electrophoreses were optimized by using a double gradient of 
acrylamide (6 – 10%) and denaturant (30-70%), which increased the separation 
between distinct PCR products. The use of GelRed (Biotium) improved the DNA 
visualization in the DGGE gel. To recover the DNA from the DGGE gels the gel 
slices were excised, shredded in a bead beater, and the DNA was allowed to diffuse 
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into sterile water overnight. The use of primers containing specific linkers allowed 
the entire amplified PCR product to be sequenced and then analyzed.  
The optimized 16S rRNA gene PCR-DGGE method was used to analyze 50 
tissue biopsy samples chosen randomly from our collection. The results were 
compared to those of the Memorial Hermann Hospital Clinical Microbiology 
Laboratory for the same samples. The molecular method was congruent for 10 of 
the 17 (59%) culture negative tissue samples. In 7 of the 17 (41%) culture negative 
the molecular method identified a bacterium. The molecular method was congruent 
with the culture identification for 7 of the 33 (21%) positive cultured tissue samples. 
However, in 8 of the 33 (24%) the molecular method identified more organisms. In 
13 of the 15 (87%) polymicrobial cultured tissue samples the molecular method 
identified at least one organism that was also identified by culture techniques. 
Overall, the DGGE analysis of 16S rDNA is an effective method to identify bacteria 
not identified by culture analysis. 
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INTRODUCTION 
 
Musculoskeletal Infections 
Musculoskeletal infections can be defined as infections of the bone and 
surrounding tissues (29). These infections include various medical conditions: 
osteomyelitis (bone infection), septic arthritis (infection of the synovial membrane of 
joints), and pyomyositis (skeletal muscle infections) (11, 29).  Generally, a 
physician’s initial diagnosis of a musculoskeletal infection is based on the presence 
of typical clinical symptoms, which may include high fever, malaise, localized pain, 
inflammation, pus and loss of function of the involved extremity. In cases of arthritis, 
swelling of the affected joint may develop (11, 21). A rapid diagnosis of 
musculoskeletal infections is important to prevent complications and aid in the 
recovery. The physician’s diagnosis should be confirmed by culture analysis, which 
is the gold standard for pathogen identification (46, 47). A bone or tissue biopsy of 
the infected area or aspiration of the joint fluid are the samples most likely to give a 
positive culture (17). However, the current clinical laboratory methods are frequently 
inadequate for the identification of the causative agents. Recent case reviews and 
my own data, identify a large percentage (25-50%) of confirmed musculoskeletal 
infections for which no pathogen is identified in culture (17, 47). It has been stated 
that for osteomyelitis cases, “the most important step is to isolate the offending 
organisms so that the appropriate therapy can be chosen” (27). A possible solution 
to decreasing the number of false negative cultures is to use a method that does not 
require bacterial growth. This is important because other published studies have 
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demonstrated that bacterial diversity is severely underestimated when based on 
culture techniques. It has been estimated that less than 1% of the organisms in 
nature are cultivable (32). The application of molecular techniques in medical 
diagnostics of infection diseases should provide increased sensitivity in pathogen 
identification (6, 14, 43, 48). 
 
Molecular techniques for detection and identification of bacteria 
Several molecular techniques have been used for identification of bacterial 
pathogens.  The polymerase chain reaction (PCR) amplification, followed by 
sequence analysis of the product is one molecular technique that can definitively 
identify a known organism. PCR amplification allows for selective nucleic acid 
sequences to be copied and amplified through repeating cycles of denaturing, 
primer annealing, and elongation of DNA (40). In a study by El-Eragi, et al. (14) this 
particular molecular method was used to identify Mycobacterium tuberculosis in 
patients suspected of having pulmonary tuberculosis. This study consisted of 135 
DNA isolates that were cultured from patients. The isolated DNA was PCR amplified 
by primers designed for the specific amplification of the rpoB gene. PCR 
amplification of the DNA samples confirmed the identification of M. tuberculosis and 
provided evidence that their PCR amplification and sequence analysis was 100% 
accurate in identification of the pathogen (14). However, this method of identification 
required that the bacteria were cultured before the samples were used as template 
in the PCR. 
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Antibody recognition is another molecular technique that has been shown to 
aid in pathogen identification. In one study by Wang, et al. (43) anti-Salmonella-
antibody-conjugated to oval-shaped gold nanoparticles easily and specifically 
identified Salmonella typhimurium in cultured samples where Escherichia coli was 
also present. This identification method for S. typhimurium was based on the 
observation of the colorimetric change when aggregation of the nanoparticles 
occurred due to binding to the bacteria present (43). This study  also required that 
the bacteria were first cultured and then used for the molecular detection technique.  
A third molecular technique is the restriction digest of DNA to determine the 
identity of an organism. Zhan, et al. (48) used HpyCH4 III endonuclease to 
differentiate Legionella pneumophila from non- L. pneumophila stains. In this study, 
42 ATCC strains of  L. pneumophila and of non-L. pneumophila were cultured and 
DNA isolation was performed. The enzyme restricted the DNA from L. pneumophila 
differently than non-L. pneumophila strains giving different size fragments when the 
samples were electrophoresed through an agarose gel (48). Identification was 
based on the pattern of the restriction fragments.  
 All three of these molecular techniques required the bacteria to be cultured 
and were designed to detect a specific organism. One molecular technique, a 
microarray, also detects specific organisms, but can at one time detect several 
hundred specific organisms. This characteristic of a microarray is an advantage 
when the organism of interest is thought to be among a group of organisms. In one 
study, Harrington, et al. (20) designed a microarray with 16S rDNA probes that 
would identify 162 gastrointestinal bacteria. Fecal samples were obtained from 
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healthy individuals or patients suffering from ulcerative colitis and the genomic DNA 
was extracted using the QIAamp DNA Stool Mini Kit (Qiagen). In this study, the 
microarray results were sensitive and provided new evidence of the complex 
population of gastrointestinal tract bacteria. However, it must be stressed that all of 
these molecular techniques require some knowledge about the suspected bacteria 
to be identified.  
 Some molecular techniques allow for unbiased screening of bacteria. These 
methods usually include using PCR amplification of the 16S rRNA gene, followed by 
sequence analysis for identification. The 16S rRNA gene has been used to examine 
bacterial phylogeny and taxonomy, since it was first studied by Carl Woese in 1970s 
and the collection of 16S rRNA gene sequences has grown each year (36). The 
16S rRNA gene is unique in that it is present in essentially all bacteria. The function 
of the gene has not changed over time and it is of sufficient size (1,500 bp) for DNA-
based bioinformatics (22). The 16S rRNA gene is composed of alternating regions 
of DNA that are conserved among all bacterial species and DNA that is variable or 
unique at the species level (Figure 1). This characteristic allows for primers 
designed to hybridize to the conserved regions of the gene, to amplify the desired 
variable sections of the DNA, so that the latter regions can be used to speciate 
among the thousands of known bacteria (3, 9, 45).  
The 16S rRNA gene amplification and sequencing method has been used in 
various studies to detect and identify bacteria (40).  Al Masalma, et al. (1) identified 
bacteria in brain abscesses using PCR amplification followed by cloning of the PCR 
amplified 16S rDNA and then DNA sequence analysis of the inserted PCR  
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Figure 1: E. coli 16S rRNA gene sequence annotated with bacteria and 
“universal” priming sites and variable regions V1–V9. The sequence is color 
coded to indicate bacterial sequence variability. Dark red = totally conserved. Red = 
conserved. Black = variable. Blue = highly variable. Green = > 75% variable. Green 
= variable regions. Black = priming sites. From reference # 3.
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fragment.  Cloning was used in this study to separate mixed species PCR products 
in order to obtain a readable DNA sequence for analysis. The separation of PCR 
products is required if more than one species of bacteria is present in a sample. 
Cloning allows for a single PCR product to be incorporated into a vector, and then 
transformed into one E. coli cell. Colonies arising from the individual E. coli cells 
carrying the vector and insert are isolated. In this study in which 125 colonies per 
specimen were analyzed, it was determined that the molecular technique identified 
more bacterial species than culture analysis. Some of these species included the 
anaerobes, Fusobacterium nucleatum, Porphyromonas endodontalis, and 
Prevotella oris. M. faucium was another  bacterial species identified that had never 
been previously associated with brain abscesses. Bittar, et al. (6) used a similar 
molecular technique to identify pathogens in cystic fibrosis patients. However, in this 
study only 40 colonies per specimen were analyzed. Since cloning randomly 
incorporates the PCR products into the vector, the number of colonies needed for 
analysis is large to provide a high probability that all the unique PCR product 
sequences amplified are identified. This study also identified bacterial species that 
had not previously been observed in cystic fibrosis patients.  
A more recent molecular technique, termed “pyrosequencing” has been used 
to bypass the cloning step in the analysis of the 16S rRNA gene. In this approach 
the DNA sequencing procedure examines many single strands of DNA. This is 
accomplished using a method termed “sequencing by synthesis” (Figure 2).  
“Sequencing by synthesis” occurs using a DNA polymerase that generates 
inorganic pyrophosphate each time it adds a nucleotide. The pyrophosphate forms 
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Figure 2: Theory of pyrosequencing. Each peak in the pyrograms represents a 
pulse of light detected in the instrument. From reference # 15. 
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ATP and there is an ATP-dependent conversion of luciferin to oxyluciferin. When 
oxyluciferin is formed it causes the emission of light pulses.  The amplitude of each 
light pulse is directly related to the presence of nucleosides and each type of 
nucleotide is released separately. This means that for a single time period only one 
type of nucleotide is released and if that nucleotide is incorporated into the DNA 
sequence a light pulse will be detected. If the light pulse is doubled then two 
nucleotides of the same type were incorporated in the DNA sequence. 
Pyrosequencing allows thousands of sequences to be generated from one PCR 
reaction. However, one significant limitation of pyrosequencing is that the DNA 
sequence retrieved is usually no longer than 400 bases (15). In one clinical study by 
Dowd, et al. (13) 193,890 sequences were generated and analyzed from 4 samples. 
Using the pyrosequencing technique the authors found greater diversity in chronic 
wounds then had previously been identified by culture techniques. Specially, the 
pyrosequencing method detected more strict anaerobes in the chronic wound 
samples than did the culture method. This new sequencing technique is rapid and 
sensitive, but at this time it is still too costly for routine use to identify pathogens. For 
general identification of bacterial pathogens, a molecular method that is unlimited in 
the number of detectable species and is not prohibitively costly would be useful.    
10 
 
16S rRNA gene PCR-DGGE molecular method 
The first goal of this project was to test a rapid, sensitive, and cost-effective 
molecular technique that could identify all possible bacterial pathogens in 
musculoskeletal infections. The second goal was to apply this method in a pilot 
study of 50 human tissue samples. The molecular method of choice used PCR 
amplification of the 16S rRNA gene to identify all possible bacterial species. If all of 
the specimens were monomicrobial, then direct sequence analysis of the initial PCR 
product could be used for identification of the bacterial pathogens. However, a 
complication to this approach was that the majority of musculoskeletal infections are 
polymicrobial, which prohibited direct DNA sequencing of the initial 16S rDNA PCR 
product. One way to solve this problem was to use denaturing gradient gel 
electrophoresis (DGGE) to separate the PCR products into individual bands based 
on their melting point. The separation of the PCR products is based on the principle 
that each double-stranded DNA (dsDNA) fragment has a unique denaturation point, 
which is based on the order of the specific nucleotides of which it is composed. 
When DNA is in a denaturing environment, it will begin to denature in specific 
regions. The temperature at which the DNA begins to denature is called the melting 
point temperature. Chemical reagents, such as urea and formamide, can also be 
used to denature dsDNA. The differences in denaturation points of dsDNA can be 
detected by electrophoresis through an acrylamide gel containing a gradient of urea 
and formamide. To create greater separation between distinct dsDNA, the 
concentrations of urea and formamide can be modified. By increasing the gradient 
concentrations a larger range of denaturing conditions can be provided. A 
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denaturant gradient is formed by using gradient maker. A constant temperature of 
60°C also contributes to the denaturation of the dsDNA. Once the dsDNA starts to 
denature, its movement through the acrylamide gel will be arrested.  The dsDNA 
with a lower denaturation point will migrate and stop earlier (or higher) in the 
acrylamide gel whereas, the dsDNA with a higher denaturation point will migrate 
longer and stop lower in the acrylamide gel. The differences in migration will result 
in DNA bands at different positions in the DGGE gel.  
The 16S rRNA gene PCR-DGGE molecular method should allow the 
identification of all causative bacteria present in the tissue samples. This analytical 
technique allows a mixture of PCR products of the same length that electrophorese 
through agarose gels as one band, to be separated into different bands that can 
then be used as template for DNA sequence analysis.  In this case, the DGGE 
allows for the detection of individual bacterial species in polymicrobial infected 
tissue, which is critical for identification and assessing diversity (10). Combining the 
16S rDNA amplification and the DGGE techniques together should provide more 
complete information to the medical staff treating these infections than is currently 
provided by the clinical microbiology laboratory. The advantages of this alternative 
method are that it should increase sample sensitivity and the speed of detection. 
Furthermore, bacteria that are non-culturable or in low abundance can be detected 
using this molecular method.  Infections, particularly those resulting from 
polymicrobial biofilms, are difficult to eradicate, making proper identification of the 
causative agents critical for treatment.  
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METHODS 
 
Origin of bacterial control strains and experimental tissue samples 
The standard control strain used for this study was a clinical isolate of 
Staphylococcus aureus, from an osteomyelitis infection, designated UAMS-1, which 
was purchased from the American Type Culture Collection as ATCC 94250. During 
all steps of the analyses, positive and negative controls were included. The tissue 
samples were obtained from the Memorial Hermann Hospital Clinical Microbiology 
Laboratory after culture analysis was performed. The collection of specimen 
occurred throughout the study; some were collected as early as 2007. All the 
tissues used in this study were obtained as part of our ongoing trial study, which 
has been approved by the IRB - the Committee for the Protection of Human 
Subjects at UTHSCH. All patient identification was removed and each tissue sample 
was assigned a study number. All tissue samples were stored at -20°C until DNA 
isolation from tissue was performed. The amount of time spent in storage varies for 
each specimen.  
 
DNA isolation from tissue biopsies 
DNA isolation from tissue was performed by using a modified version of the 
Puregene DNA Purification kit (Qiagen) for solid tissue. The tissue (0.5 g) was 
homogenized in cell lysis solution (500 ul) using a sterile disposable tissue grinder 
(Kendall). These steps of the protocol were performed under a tissue culture hood 
and all instrumentation and a few solutions (cell lysis solution and sterile water) 
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were exposed to UV light for 30 min before the DNA isolation was performed. The 
homogenized tissue samples were incubated for 100 min at 65°C. Afterward, 6 ul 
Proteinase K solution (20 mg/ml) was added and the sample was incubated at 55°C 
overnight. To ensure efficient lysis of the bacterial cells and complete digestion of 
cell walls, 10 ul lysotaphin (2 mg/ml) and 3 ul Lytic Enzyme Solution (Qiagen) were 
added and the samples were incubated at 37°C for 3 hrs, followed by heating to 
80°C for 5 min. This step of the protocol was optimized for S. aureus and it 
efficiently lyses other bacteria including Gram-negative organisms, such as E. coli. 
Protein precipitation was performed by adding 200 ul of protein precipitation solution 
(10 M ammonium acetate), which was followed by the placing samples on ice for 20 
min. The samples were then centrifuged at 15,000 x g for 6 min to collect the 
supernatant. The supernatant was transferred to a clean microcentrifuge tube. 
Again the sample was placed on ice for 20 min and centrifuged to collect the 
supernatant. The supernatant containing the DNA was then transferred to a clean 
microcentrifuge tube containing 700 µl 100% isopropanol. The microcentrifuge tube 
was then mixed and centrifuged at 15,000 x g for 6 min. The supernatant was 
discarded and 800 µl 70% ethanol was added to wash the DNA pellet. The samples 
were centrifuged at 15,000 x g for 2 min to position the DNA pellet at bottom of the 
tube. The ethanol was discarded and the pellet was allowed to air dry for 1 hr. The 
DNA pellet was hydrated overnight at room temperature with water that had been 
treated with ethidium monoazide bromide (EMA, 9 ug/ml) (see Results). The DNA 
isolation protocol duration was two days.  
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Initial PCR amplification  
DNA amplification was performed as follows. A positive control of S. aureus 
DNA and blank were included in all DNA amplification steps. Three different 
concentrations of the tissue-extracted DNA were used as the PCR template 
(undiluted, 1:10 dilution, and 1:100 dilution). This is an important step in the PCR 
amplification protocol because large quantities of DNA can decrease the efficiency 
of the PCR reaction. The PCR amplification cocktail included 10X buffer, 5X Q 
buffer, 25 mM MgCl2, 10 mm dDNTP, the forward primer (10 pmol/ µl), the reverse 
primer (10 pmol/ µl), and HotStar Plus Taq (5 units /µl). The oligonucleotide primers 
used were designed based on the known conserved regions that will amplify 
variable regions V3, V4 and V5 of the 16S rRNA gene. The primers used were 
380F: 5’CCAGACTCCTACGGGAG GCAG‘3 and 907R: 5’ CCG TCA ATT CMT 
TTG AGT TT (3). The thermocycler was programmed for the following steps: an 
initial denaturing step of 95°C for 5 min; ten cycles of 94°C, 60°C, 72°C for 30 sec 
each; then 35 cycles of 94°C, 54°C, 72°C for 30 sec each. The final step for 
elongation of the DNA was 10 min at 72°C. The water used in the PCR contained 
EMA (9 ug/ml) to eliminate contamination in the PCR reagents and PCR tubes (see 
the Results section below). A 1.5% agarose gel electrophoresis was performed after 
every DNA amplification to ensure amplification and no contamination. 
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Generation of the PCR product for DGGE 
A second DNA amplification was performed to generate a PCR product for 
DGGE analysis. This amplification conditions was identical to the initial PCR 
reaction, except that the oligonecleotide primers used amplified the variable regions 
V3 and V4 only, and the reverse primer contained a high GC region on the 5’ end. 
This region was selected because an alignment of the 16S rRNA gene of the most 
reported bacterial pathogens in musculoskeletal infections revealed that these 
variable regions provide enough sequence information to speciate almost all of the 
pathogens (Table 1). The primers used were 380F (see above) and 759R 
CGV3V4:5’CGCCGCGCGCGGCGGGCGGGGCGGGGCGGGGGGCCGCATT 
YCACCKCTACAC’3. The template for this PCR reaction was the PCR product from 
the first PCR amplification, which had been diluted to less than a nanogram of DNA 
per microliter (usually a 1:100 dilution).  
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Bacterial species associated with musculoskeletal infections 
1. Achromobacter  xylosoxidans (9) 
2. Acinetobacter baumannii* (9) 
3. Acinetobacter calcoaceticus (9)  
4. Acinetobacter lwoffii* (16) 
5. Actinomyces israelii* (9) 
6. Actinomyces meyeri (9) 
7. Aerococcus viridans (9) 
8. Alcaligenes faecalis (16) 
9. Alkane-degrading soil bacterium MVAB Hex1 (9) 
10. Anaerococcus vaginalis (16) 
11. Arcanobacterium pyogenes (9) 
12. Bacillus cereus (9) 
13. Bacteriodes fragilis* (9) 
14. Brucella melitensis (9) 
15. Burkholderia cepacia (9) 
16. Burkholderia gladioli (39)  
17. Campylobacter jejuni (9) 
18. Citrobacter diversus (9) 
19. Citrobacter freundii (19) 
20. Clostridium botulinum* (9) 
21. Clostridium septicum (9) 
22. Comamonas terrigena (16) 
23. Corynebacterium confusum(18) 
24. Corynebacterium jeikeium* (9) 
25. Corynebacterium striatum (16) 
26. Coxiella burnetii (9) 
27. Eikenella corrodens (19) 
28. Enterobacter aerogenes* (9) 
29. Enterobacter hormaechei*(9) 
30. Enterococcus gallinarum (9) 
31. Enterococcus faecium* (9) 
32. Escherichia coli*(9)  
33. Escherichia vulneris (9) 
34. Faecalibacterium prausnitzii (9) 
35. Francisella tularensis (9) 
36. Fusobacterium alocis (9) 
37. Fusobacterium equorum (9) 
38. Fusobacterium naviforme (9) 
39. Fusobacterium necrophorum (9) 
40. Fusobacterium nucleatum (9) 
41. Fusobacterium periodonticum (9) 
42. Fusobacterium sulci (9) 
43. Granulicatella adiacens (16) 
44. Haemophilus aphrophilus (9) 
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45. Haemophilus parahaemolyticus (9) 
46. Haemophilus parainfluenzae (9) 
47. Haemophilus paraphrophilus (9) 
48. Haemophilus pittmaniae (9) 
49. Kingella kingae (16) 
50. Klebsiella pneumonia* (9) 
51. Leclercia adecarboxylata (16) 
52. Leptospira interrogans (9) 
53. Listeria grayi (9) 
54. Listeria monocytogenes (9) 
55. Moraxella catarrhalis (9) 
56. Morganella morganii* (16) 
57. Mycobacterium avium (9) 
58. Mycobacterium fortuitum (9) 
59. Mycobacterium goodii (8) 
60. Mycobacterium gordonae (9) 
61. Mycobacterium haemophilum (38 
62. Mycobacterium intracellulare (9) 
63. Mycobacterium kansasii (9) 
64. Mycobacterium malmoense (44) 
65. Mycobacterium marinum (42) 
66. Mycobacterium tuberculosis (9) 
67. Mycobacterium wolinsky (8) 
68. Mycobacterium xenopi (12) 
69. Mycoplasma pneumoniae (24) 
70. Neisseria lactamica (9) 
71. Neisseria meningitis (28) 
72. Nocardia brasiliensis (9) 
73. Oligella urethralis (9) 
74. Pasteurella multocida* (37) 
75. Peptoniphilus lacrimalis* (16) 
76. Peptostreptococcus hareii* (16) 
77. Peptostreptococcus micros* (9) 
78. Porphyromonas asaccharolytica (16) 
79. Porphyromonas somerae* (16) 
80. Prevotella bivia* (16) 
81. Prevotella buccalis* (16) 
82. Prevotella disiens (19) 
83. Proteus mirabilis* (9) 
84. Proteus vulgaris (9) 
85. Providencia stuartii (19) 
86. Pseudomonas aeruginosa* (9) 
87. Pseudomonas putida (19) 
88. Pseudomonas stutzeri* (33) 
89. Ralstonia pickettii (35) 
90. Rhodococcus equi (9) 
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91. Rickettsia rickettsii (9) 
92. Rochalimaea henselae (9) 
93. Salmonella paratyphi A (9) 
94. Salmonella typhimurium (9) 
95. Serratia marcescens* (9) 
96. Shewanella algae (7) 
97. Shigella dysenteriae (9) 
98. Sphingobacterium mizutae (9) 
99. Staphylococcus aureus* (9) 
100. Staphylococcus capitis (16) 
101. Staphylococcus caprae (9) 
102. Staphylococcus epidermidis* (9) 
103. Staphylococcus haemolyticus (9) 
104. Staphylococcus hominis (9) 
105. Staphylococcus intermedius (9) 
106. Staphylococcus lugdunensis (9) 
107. Staphylococcus saprophyticus (9) 
108. Staphylococcus schleiferi (9) 
109. Staphylococcus simulans* (9) 
110. Staphylococcus warneri (9) 
111. Stenotrophomonas maltophilia (16) 
112. Streptococcus agalactiae* (28) 
113. Streptococcus gordonii (9) 
114. Streptococcus sp. 'group G' * (19) 
115. Streptococcus iniae (25) 
116. Streptococcus pyogenes (9) 
117. Streptococcus salivarius (9) 
118. Streptococcus uberis (9) 
119. Streptococcus viridans (19) 
120. Veillonella parvula (16) 
121. Vibrio cholerae (9) 
122. Yersinia enterocolitica (9) 
 
Table 1: Bacterial species in the 16S rRNA gene alignment previously 
identified as the causative agents in musculoskeletal infections. Names of 
bacteria species reported to be the causative agents of musculoskeletal infections, 
which was used for the alignment of the 16S rRNA gene that revealed that variable 
regions 3 and 4 provide enough sequence information to speciate most of the 
pathogens. Bacterial species with an asterisk (*) indicate that it was identified by the 
16S PCR molecular method. References are listed in the parentheses. 
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Denaturant gradient gel electrophoresis 
After obtaining the second PCR product, this PCR product was separated 
using DGGE, which used the Bio-Rad DCode system for the casting of the gel and 
electrophoreses (4). The denaturing gradient gel used was composed of 6-10% 
acrylamide/bis and a 30-70% denaturing solution of urea and formamide. The 30% 
denaturing solution contains 12 ml of formamide and 12.6 g of urea. The 70% 
denaturing solution contains 28 ml of formamide and 29.4 g of urea. The proper gel 
concentration was determined by comparing band migration and separation in a 
variety of gel concentrations: 6%, 8%, 6-10%, and 8-10%, acrylamide/bis and 30-
70% and 40-70% denaturant solution. The addition of 10% ammonium persulfate 
and TEMED served to catalyze the gel polymerization. The gradient gel was 
allowed to polymerize for 2 hrs at room temperature and was stored at 4°C 
overnight. The running buffer (0.5 TAE) was heated to 60°C before the samples 
were loaded into the wells. Each sample contained PCR products varying in DNA 
concentration (200 ng to 1ug) and 2x loading dye. The minimum DNA 
concentration, 200 ng, that can be detected with a UV light source and GelRed 
Nucleic Acid stain (Biotium) at 3X concentration (5) was determined by loading 
decreasing amounts DNA of the control stain of S. aureus. The duration of 
electrophoresis was 15 hrs at 100 V. This condition was determine by comparing 
band migration and separation in gels that had run for various times and voltages. 
Once electrophoresis was completed the gel was removed from the DGGE 
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chamber and stained with GelRed stain (3X) for 45 min. The gel was viewed under 
UV light and all bands were excised using sterile scalpel blades.  
 
DNA extraction of DNA from DGGE bands 
Several methods for DNA extraction from the DGGE bands were explored. 
One method was extraction of DNA using the QIAquick gel extraction kit (Qiagen) 
modified for acrylamide gels based on the manufacturer’s recommendations. 
Second, a small piece of gel slice was placed directly into the PCR tube to serve as 
the DNA template in a PCR reaction. Third, the gel slice was cut into pieces and 
placed in a centrifuge tube with water and left overnight. The DNA would then 
diffuse into the water, which served as the template for PCR. The fourth method 
involved shredding the gel slice by bead beating it in a 1.7 ml microcentrifuge tube 
containing 0.2 g of glass beads in 0.5 ml of water overnight at a setting of 4°C. This 
solution then served as the DNA template for PCR. The fourth method was the most 
successful template to produce PCR products, as a result it was the method of 
choice and included in the optimized protocol.    
 
 
PCR of DNA extracted from DGGE bands 
DNA amplification of the DGGE gel extracted DNA was performed using Fail 
Safe polymerase (Epicentre Biotechnologies). This polymerase was tested and was 
more efficient then the Hot Star Plus Taq (Qiagen), used in the initial PCR.  
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In the development of this method a few other were tested. First, a shorter 
reverse primer without the GC region was used, however, with this primer the PCR 
was less efficient. In addition, the GC reverse primer containing the long GC region 
was tested and showed better amplification of the DNA, but it produced an 
extensive amount of primer dimers. These primer dimers were a problem in the 
subsequent sequencing reaction. An agarose gel extraction using the Mini Qiagen 
kit was used to purify the PCR product in this case.  
The primers used were forward and reverse primers that contained linker 
regions with either AT or GC in content (31). 380F-AT-M13: 5’- GTAAAACGA 
CGGCCAGTAATTAAAATAAAAATGAAAAAAACCAGACTCCTACGGGAGGC -3’. 
759R-CG-M13: 5’- CAGGAAACAGCTATGACGGGCGGGGCGGGGGCACGG 
GGGGCGCATTYCACCKCTACAC -3’. These primers were chosen to create a 
buffer region for the sequencing reaction. This resulted in a DNA sequence that 
begins 40 base pairs upstream of the actual bacterial DNA sequence. This ensured 
that the entire 16S rDNA sequence was available for analysis. Also, these primers 
do not form primer dimers and as a result an agarose gel extraction step is not 
required. These primers were shown to be the most efficient in production of PCR 
products and allowed complete bacterial DNA sequencing.  
 
DNA sequencing and analysis of the PCR products extracted from the DGGE 
gel slices 
To perform DNA sequencing, the purified PCR products were first incubated 
with the Exo SAP-IT enzyme to digest the single-stranded DNA in the reaction, 
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unconsumed dNTPS and primers. ExoSAP-IT contains two hydrolytic enzymes, 
Exonuclease I and Shrimp Alkaline Phosphatase. The Exonuclease I enzyme 
removes the unused primers in the PCR reaction. The Shrimp Alkaline 
Phosphatase removes the residual dNTPs from the PCR reaction (41). The DNA 
sequencing reaction was performed as followed: 20 ng of the PCR product was 
added to Big Dye, 5X sequencing buffer, and forward primer (10 pmol/ µl). The Big 
Dye and 5X were reagents supplied by the Center for Clinical and Translational 
Sciences Genetics Core Lab of the University of Texas Medical School at Houston. 
The DNA sequencing reaction was performed on a thermocycler with the following 
program for 35 cycles: 96°C for 15 sec, 55°C for 15 sec, 65°C for 2 min. The 
sequencing reaction products were purified using Sam solution and Big Dye 
Xterminator, which were supplied by the Genetics Core Lab. The sequencing 
products were analyzed using the ABI 3137 XL in the Genetics Core Lab. DNA 
sequencing was performed on the control strains and the DGGE PCR products. 
Even though the DGGE PCR products appeared to not have primer dimers in the 
agarose gel, the sequence obtained from some of these PCR products was not 
always reliable. Several modifications of the sequencing reaction were tested, 
including increasing the amount of nucleotide dyes used per sequencing reaction, 
decreasing the DNA concentration used in sequencing reaction to 20 ng, and 
altering the temperatures of the thermocycler steps. None of the modifications 
tested significantly improved the DNA sequence quality. However, the addition of 
linker primers (see above) (31) to the 3’ end and the 5’ end of the PCR product 
used for sequence analysis did improve the percentage of identify to the known 
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sequences. The linker primers allowed for the full PCR product sequence to be 
analyzed.  DNA sequences that did not have significant background signal were 
analyzed by searching the bacterial database (30) with the complete sequence 
using the National Center for Biotechnology Information’s Basic Local Alignment 
Search Tool (BLAST) nucleotide-nucleotide server (2). Identification was based on 
the comparison that provided the highest degree of identity. All identifications 
including speciation were defined as having a > 90% identity to a known 16S rDNA 
sequence in the nucleotide database when compared with the BLAST sequence 
results.  
Overall the 16S rRNA gene PCR-DGGE method includes several critical 
steps: DNA extraction from tissue biopsies, amplification of the bacterial DNA, PCR 
product separation by DGGE, amplification of the gel-extracted DNA, and DNA 
sequencing and analysis (Figure 3).  This method can detect the presence of 
bacteria in 3 days by PCR amplification of the 16S rRNA gene and can identify the 
organisms in 5 days by DNA sequence analysis.  
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Figure 3: Overview of 16S rRNA gene PCR-DGGE method. This method 
includes DNA extraction from tissue biopsies, amplification of the bacterial DNA, 
PCR product separation by DGGE, amplification of the gel-extracted DNA, and DNA 
sequencing and analysis.
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RESULTS 
Section 1: Optimization and validation of the method 
Isolation of DNA  
Limit of detection for DNA extraction 
Efficient lysis of the bacterial cells is important to achieving high efficiency 
and sensitivity for the 16S rRNA gene PCR-DGGE molecular detection technique. 
The isolation of DNA protocol used in this study was modeled after the Puregene 
DNA Purification kit (Qiagen). Several modifications were made to the Puregene kit 
(Qiagen) that increased the efficiency of bacterial cell lysis. S. aureus was used as 
a model bacterial cell because it is a common pathogen in musculoskeletal 
infections and requires specific steps for efficient cell lysis. The high degree of 
crossing-linking of the pentaglycine bridge between the ε-amino group of lysine and 
the terminal D-alanine of an adjacent tetrapeptide makes the S. aureus cell wall 
extremely strong and difficult to lyse (23). For efficient cell lysis of S. aureus the 
addition of lysostaphin (2 mg/ml) to the DNA isolation protocol was important. To 
test how efficient the DNA isolation protocol was, an experiment using a range of S. 
aureus cells (2 to 2,000) was used in the DNA isolation protocol. The PCR products 
of the resulting extracted DNA were electrophoresed through a 1.5% agarose gel 
and visualized after staining with ethidium bromide. The PCR product resulting from 
the extracted DNA showed that this DNA isolation protocol was able to detect at 
least 20 bacterial cells (Figure 4). These data indicate that this method is very 
sensitive. It is interesting to note that when less DNA that was used as the template, 
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Figure 4: The limit of detection for DNA extraction. The PCR products of 
extracted DNA from different numbers of S. aureus cells ranging from 2 to 2,000 
was electrophoresed through a 1.5% agarose gel and visualized after staining with 
ethidium bromide. The PCR product of the extracted DNA shows that the DNA 
isolation protocol method is able to detect at least 20 bacterial cells.
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there was more PCR product synthesized.  These results indicate that the PCR 
reaction is a more effective reaction with a limited amount of DNA template. 
 
PCR amplification 
The optimization of EMA concentration 
Ethidium monoazide bromide (EMA) is a photoreactive chemical that is an analogue 
of ethidium bromide. EMA contains an azide group in the eighth position, whereas 
ethidium bromide contains an amino group in that position (Figure 5). When EMA is 
exposed to a long wavelength (> 400 nm), the azide group covalently crosslinks 
with nucleic acids. Any nucleic acid that becomes crosslinked with EMA will be 
unable to serve as template for PCR amplification reaction (34).  The ability of EMA 
to bind to nucleic acids can be used to eliminate contaminates from being amplified 
along with the template. This is important because amplification of contaminates 
can give misleading results. In this study EMA was only used for the pretreatment of 
the PCR reaction mix prior to the addition of the template DNA. To determine the 
appropriate range of EMA necessary for the elimination of contamination in PCR 
reactions, 0.1 pg of S. aureus DNA was added to each PCR reaction to serve as 
artificial contamination in one of the PCR amplification reagents. Also added were 
various amounts of EMA: 5 ug/ml, 10 ug/ml, 15 ug/ml, 20 ug/ml; and there was a 
tube with no added EMA. After the addition of the EMA the PCR reaction was 
exposed to a halogen light for 5 minutes. All the PCR reactions were amplified as 
described previously. The PCR products were electrophoresed through 1.5% 
agarose gel and visualized after staining with ethidium bromide.  The PCR reaction  
28 
 
 
 
 
 
 
 
 
 
 
 
 
F 
 
 
Figure 5: Structural comparison of ethidium monoazide bromide to ethidium 
bromide. Ethidium monoazide bromide (EMA) (Panel A) is a photoreactive 
chemical that is an analogue of ethidium bromide (Panel B). EMA contains an azide 
group in the eighth position where as ethidium bromide contains an amino group. 
When EMA is exposed to a long wavelength (> 400 nm) the azide group covalently 
cross links with nucleic acids and prevents their amplification in a PCR reaction.
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that contained no EMA and no standard template (blank) showed amplification of 
the artificial contaminant DNA. However, when EMA at 5 ug/ml or more was added 
to the PCR reaction before the addition of the standard template DNA, no 
amplification of the artificial contaminant DNA was observed. This is important to 
ensure that reagent contamination was not amplified during the PCR reaction. The 
PCR reactions in which EMA was added at concentrations of 10, 15, and 20 ug/ml 
seemed to be less efficient in amplification of the template DNA (Figure 6).  We 
chose to use 10 ug/ml of EMA to decontaminate the reagents in the standard 
protocol.  However, 5 ug/ml of EMA would have been a better choice.  
 
The limit of detection for PCR amplification 
The PCR amplification of the chromosomal DNA is an important step for the 
16S rRNA gene PCR-DGGE method. It is essential that this step be efficient and 
sensitive in amplifying the variable regions V3, V4, and V5 of the 16S rRNA gene. 
To determine the efficiency and sensitivity of the PCR amplification, various 
amounts of S. aureus DNA were used as template for the PCR reaction (0.01 pg to 
1 pg). This range of S. aureus DNA is approximated to be equal to the DNA in 3 - 
325 cells base on a chromosome of 3 Mb per cell (30). The PCR amplification was 
performed using the protocol described previously. The PCR products were 
electrophoresed through a 1.5% agarose gel and visualized after staining with 
ethidium bromide. The agarose gel showed that the limit of detection was between 
0.01 pg – 0.05 pg of S. aureus DNA, which is equivalent to 3-15 cells.   
30 
 
 
 
Figure 6: The range of EMA necessary to eliminate PCR contamination for 
PCR. S. aureus DNA (0.1 pg) was added to each PCR reaction to serve as an 
artificial contamination of the PCR amplification reaction. Also added were various 
amounts of EMA, 5 µg/ml, 10 µg/ml, 15 µg/ml, 20 µg/ml or no EMA. After the 
addition of the EMA the PCR reaction was exposed to a halogen light for 5 min. All 
the PCR reactions were subjected to PCR amplification cycle described previously. 
The PCR products were electrophoresed through a 1.5% agarose gel and 
visualized after with ethidium bromide.  The PCR reaction that contained no EMA 
and no standard template showed amplification of the artificial contaminates. 
However, when 5 ug/ml of EMA or above was added to the PCR reaction before the 
addition of the template DNA, no amplification of the artificial DNA contamination 
was observed.
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A PowerWave microplate spectrophotometer (BioTek) was used with a Gen5 data 
analysis software to determine the S. aureus DNA concentration used (Figure 7). 
A second PCR reaction was performed to determine if the PCR amplification 
would be altered in its efficiency in the presence of human DNA. Two different 
concentrations of human DNA were added to the PCR reactions: 19 ng and 190 ng. 
These concentrations reflect the concentration of the human DNA that was typically 
present in 1:10 and 1:100 dilutions of tissue samples, respectively. Each 
concentration of human DNA was added to PCR reactions with various amounts S. 
aureus DNA as template, 0.01 pg, 0.5 pg, 1 pg, and 125 pg. As described above, 
DNA concentrations were determined with a microplate spectrophotometer. The 
PCR amplification was performed according to the PCR amplification protocol 
described previously. The electrophoresis of the PCR products on a 1.5% agarose 
gel indicated that in the presence of human DNA less than 100 ng the efficiency of 
PCR amplification is greater and the sensitivity is increased from 0.05 pg to 0.01 pg 
of S. aureus DNA (Figure 8). This is somewhat surprising and interesting in the light 
that all of the samples that were analyzed contained human tissue.  The results 
from both PCR amplification experiments showed that the presence of human DNA 
in the PCR reaction seemed to increase the sensitivity of the reaction. In the 
presence of human DNA the limit of detection was decreased to 0.01 pg of S. 
aureus DNA.  
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Figure 7: The limit of detection for PCR using S. aureus DNA as template. DNA 
from S. aureus cells ranging from 0.01 pg to 1 pg was used as template in the PCR 
amplification reaction using PCR conditions describe previously. The limit of 
detection for PCR amplification using S. aureus DNA is at least 0.05 pg. 
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Figure 8: The limit of detection for PCR using S. aureus DNA as template in 
the presence of human DNA. Two different concentration of human DNA was 
added to the PCR reaction, 2 ng and 19 ng. Each concentration of human DNA was 
added to PCR reactions with various amounts S. aureus DNA as template, 0.01 pg, 
0.05 pg, 1 pg, and 125 pg. The PCR amplification was performed according to the 
protocol describe previously. The PCR products were electrophoresed through a 
1.5% agarose gel and visualized after with ethidium bromide. The results from the 
agarose gel show that the limit of detection for PCR using S. aureus DNA in the 
presence of human DNA is at least 0.01 pg.  
 
 
Human DNA concentration 
Template concentration 
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DGGE gel electrophoresis 
Determining the most appropriate preparation of the DGGE gel 
Two methods to distribute the unpolymerized acrylamide into the DGGE 
system were tested: a 475 gradient former that is included in the  Bio-Rad DCode 
system and a gravity gradient maker. The 475 gradient former uses two syringes to 
hold the different liquid acrylamide concentrations, which are moved by a calibrated 
wheel to form the gel (Figure 9). The second method uses a gravity gradient maker 
that is connected to a peristaltic pump. To test the two gradient forming devices the 
high concentration denaturing solution was stained with red food dye. Once the gels 
solidified they were scanned and pixel analysis determined that the gravity gradient 
maker made the gradient gel with the most gradual and consistent gradient.  
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Figure 9: Bio-Rad DCode DGGE apparatus. The DGGE gradient maker uses a 
calibrated wheel apparatus to dispense the high and low denaturing solution to cast 
a gradient gel. The wheel applies selective pressure to two syringes containing the 
high and low concentrations of the denaturing solution. The two solutions flow 
through the plastic tubing where they become mixed and poured in between two 
glass plates.
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Determining the appropriate amount of acrylamide and denaturing gradient 
It is necessary for the DGGE gradient be large enough to separate closely 
related PCR products. To test which concentration gradient would be the most 
appropriate, several concentrations of acrylamide and denaturing gradient were 
tested. These concentrations included: 8%, 8-10%, and a 6-10% acrylamide. These 
gels were loaded with 500 ng of PCR products amplified from the 16S rDNA of 
Staphylococcus aureus, Enterobacter hormaechei, and Acinetobacter baumannii. A. 
baumannii and E. hormaechei were chosen because the two bacterial DNA PCR 
products migrate and stop at the top and bottom of the DGGE gel, respectively. The 
denaturing solutions tested were 40-70% and 30-70%. From these trials, the gel 
concentration of 6-10% acrylamide and 40-70% denaturing solution was determined 
to have the best separation for the bacterial DNA tested (Figure 10). 
 
Determination of the most appropriate duration of denaturing gradient gel 
electrophoresis 
It was important to determine the amount of time necessary for the PCR 
products to migrate to their melting point positions, otherwise PCR product 
separation may not occur. To determine the correct running time for the DGGE gel, 
340 ng of S. aureus DNA was loaded into the denaturing gradient gel wells every 
two hrs for 10 hrs.  The DNA bands at 8 and 10 hr migrated the same distance in 
the denaturing gradient gel. This shows that the DGGE needs at least 8 hrs for 
maximal migration (Figure 11). 
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Figure 10: Determining the most appropriate amount of acrylamide and 
denaturing gradient. Panel A: This DGGE gel is comprised of 8% acrylamide/Bis 
with 40-70% denaturing solution. Panel B: This DGGE gel is comprised of DGGE 8-
10% acrylamide/Bis with 30-70% denaturing solution. Panel C : This DGGE gel is 
comprised of 6-10% acrylamide/Bis with 40-70% denaturing solution. Panel D: This 
DGGE gel is comprised of 6-10% acrylamide/Bis with 30-70% denaturing solution. 
Several concentrations of acrylamide and denaturing gradient were tested. The 8% 
acrylamide/bis and 8-10% acrylamide/bis were run with 500 ng of S. aureus, E. 
hormaechei, and A. baumannii. The denaturing solutions tested were 40-70% and 
30-70%. From these trials, the gel concentration of 6-10% acrylamide and 40-70% 
maximal migration denaturing solution was determined to have the best separation 
for the bacterial DNA tested.
A B C D
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Figure 11: Determining the most appropriate duration of denaturing gradient 
gel electrophoresis. Electrophoresis of S. aureus DNA (340 ng), which was 
applied to the gel every two hours for ten hours. The DGGE gel was composed of 6-
10% acrylamide/bis with 30-70% denaturing solution and electrophoresed at 100 V. 
The DNA bands (lanes 1 and 2) at 8 and 10 hrs migrated the same distance in the 
DGGE gel. Lane 1 = 10 hrs, lane 2 = 8 hrs, lane 3 = 6hrs, lane 4 = 4 hrs, lane 5 = 3 
hrs.
   1    2   3   4   5  
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Determination of the most appropriate amount of DNA to load into the DGGE 
Visualization of the DNA bands in the DGGE gel is important for the recovery 
and re-amplification of the DNA for sequencing analysis. To determine the amount 
of DNA needed for visualization with Gel Red stain under UV light, a range of 50 ng 
-500 ng of S. aureus and A. baumannii DNA was loaded into the DGGE gel and 
electrophoresed using our standard conditions, for 15 hrs at 100 V. The 50 ng 
loading of S. aureus and A. baumannii were still visible under UV light (Figure 12).  
 
Mixed template PCR amplification and DGGE analysis of bacterial strains  
DNA isolation from polymicrobial tissue samples would have multiple DNA 
templates for PCR amplification. To test the efficiency of PCR amplification of 
multiple templates in one reaction, DNA of three bacteria strains, S. aureus, 
Enterococcus faecalis, and Enterobacter aerogenes, were PCR amplified together 
and separately. 50 ng of each bacterial stain, S. aureus, E. faecalis, and E. 
aerogenes served as template separately for PCR amplification. Mixed template 
PCR was also performed using all three bacterial DNA as template. One PCR 
reaction contained an equal low concentration of DNA from each organism as 
template (0.5 ng). A second PCR reaction contained S. aureus (5 ng), E. faecalis 
(0.5 ng), and E. aerogenes (50 ng). A third PCR reaction contained an equal high 
concentration of DNA from each organism (50 ng). All PCR amplification products 
were electrophoresed through a DGGE gel overnight at 100V. The results from this 
experiment indicate that the efficiency of mixed template PCR amplification
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Figure 12: Determining the 
appropriate amount of DNA to 
load onto the DGGE.  
A: Electrophoresis of various 
amounts of S. aureus DNA ranging 
from 500 ng to 50 ng. 
 
 
 
 
 
B: Electrophoresis of various 
amounts of A. baumannii DNA 
ranging from 500 ng to 50 ng. 
1 = 500 ng, 2 = 250 ng, 3 = 200 ng, 
4 =150 ng, 5 =100 ng, 6 = 50 ng 
1 2 3 4 5 6 
1 2 3 4  5 6 
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decreased when multiple templates were present. However, higher magnification 
analysis of the bands indicates that DNA for all three bacteria can be observed 
when equal concentrations of the templates were present (Figure 13 and 14).  
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Figure 13: DGGE gel electrophoresis of mixed template PCR products. 
Different DNA concentrations of three bacteria strains were PCR amplified together 
and separately. The PCR products of each PCR amplification reaction was then 
electrophoresed through a DGGE gel overnight at 100 V. Lane 1 = Staphylococcus 
aureus (0.5 ng), Enterococcus faecalis (0.5 ng), and Enterobacter aerogenes (0.5 
ng). Lane 2 = S. aureus (5 ng), E. faecalis (0.5 ng), and E. aerogenes (50 ng). Lane 
3 = S. aureus (50 ng), E. faecalis (50 ng), and E. aerogenes (50 ng). Lane 4 = S. 
aureus (50 ng). Lane 5 = E. faecalis (50 ng). Lane 6 = E. aerogenes (50 ng). 
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Figure 14: Higher magnification of the DGGE gel electrophoresis of mixed 
template PCR products. A higher magnification view of  lanes 1-4. Lane 1 = S. 
aureus (50 pg), Enterococcus faecailis, and Enterobacter aerogenes (50 pg). Lane 
2 = S. aureus (5 ng), E. faecalis (50 pg), and E. aerogenes (50 ng). Lane 3 = S. 
aureus (50 ng), E. faecalis (50 ng), and E. aerogenes (50 ng). Lane 4 = S. aureus 
(50 ng). Looking closely the DGGE gel reveals bands in lanes 1-3 that are in a 
similar position to the S. aureus, pictured in lane 4.  
 1     2     3     4 
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Section 2: Results of the pilot study of fifty tissue samples 
 
Molecular analysis of 50 tissue samples 
The optimized 16S rRNA gene PCR-DGGE method was used to analyze 50 
tissue biopsy samples chosen randomly from our collection. Each tissue sample 
was subjected to the following steps of the protocol:  DNA isolation, PCR 
amplification with 16S rDNA and DGGE primers, DGGE electrophoresis, extraction 
of DNA gel slices, DNA sequencing and analysis. The DNA sequencing results 
were compared to the sequences in the NCBI non-redundant nucleotide database 
(30) with the BLAST program (2). Identification for each sample was based on 
comparison with the organism whose 16S rDNA sequence had the highest degree 
of identity. All identifications were made with > 90% identity with reference 
sequence giving by BLAST tool.  Each result was compared to the culture results of 
the Memorial Hermann Hospital Clinical Microbiology Laboratory listed in the 
Memorial Hermann Hospital Electronic Record Resource. 
In this study, 17 of the 50 (34%) tissue samples were culture negative.  The 
molecular method was congruent for ten of the 17 (59%) culture negative tissue 
samples. Six of the 10 (60%) congruent tissue samples were obtained from patients 
who were not clinically diagnosed with an infection. With this high percentage of 
clinically uninfected tissue samples, it is not surprising that the molecular method 
was congruent with ten negative culture samples. In seven of the 17 (41%) culture 
negative samples the molecular method identified an organism (Table 2).  
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Tissue 
Number  
Culture Results  16S PCR-DGGE  
23  Negative  Negative  
110  Negative  Negative  
96  Negative  Negative  
1506  Negative  Negative  
125A  Negative  Negative  
0647  Negative  Negative  
111*  Negative  Negative  
111B*  Negative  Negative  
111E*  Negative  Negative  
2217*  Negative  Negative  
2764  Negative  Streptococcus agalactiea (99%) 
1921*   Negative  Staphylococcus aureus (98%) 
2057  Negative  Abiotrophia defectiva (98%) 
111C  Negative  Staphylococcus aureus (90%) 
3460*  Negative  Gemmatimonadetes (93%) 
93*  Negative  Pseudomonas stutzer (93%) 
3514  Negative  Acinetobacter sp. (90%) 
 
Table 2: Culture negative tissue samples. Seventeen tissue samples of 50 were 
identified as negative by culture. 16S rRNA gene PCR-DGGE method identified 11 
out of 50 as negative. Red = congruency. Tissue numbers with an asterisk (*) 
indicate that Geobacillus sp. were identified in the sample by the molecular method. 
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The culture positive table can be divided into two sections, the mono-
microbial and the polymicrobial tissue samples. Eighteen of the 50 (36%) tissue 
samples were identified to be mono-microbial by culture techniques. The molecular 
method was congruent with the culture identification for seven of the 33 (21%) 
positive culture tissue samples. For three of the 18 (17%) samples identified as 
mono-microbial by the culture results, the molecular method identified more 
organisms. Fifteen of the 50 (30%) tissue samples were identified as polymicrobial 
by culture techniques. In 13 of these 15 (87%) the molecular method identified at 
least one organism that was also identified by culture techniques. In five of these 15 
(33%) samples the molecular method identified addition organisms (Table 3). 
In tissue samples 67 and 864 Enterobacter sp. was identified by the 
molecular method. However, Enterobacter has an identical DNA sequence to 
Klebsiella in the variable 3 and 4 regions which were used for the identification. This 
means that for these two tissue samples the identification of an Enterobacter could 
also mean an identification of Klebsiella. In order to differentiate between 
Enterobacter and Klebsiella specific primers to each bacterium could be used for 
PCR amplification. This is the only problem for identification that has arisen. 
Throughout tables 2 and 3, some tissue samples have asterisks, this 
indicates that Geobacillus sp. was identified in that sample by the molecular 
method. Specifically, Geobacillus stearothermophilus spores are widely used for the 
validation of moist heat sterilization in autoclaves. Autoclaves are commonly used in  
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Tissue 
Number  
Culture Results  16S PCR-DGGE  
103  Clostridium sp.  Clostridium sp. (99%) 
0689  Staphylococcus aureus  Staphylococcus aureus (99%) 
2543  MRSA  Staphylococcus aureus (99%) 
3368  MRSA  Staphylococcus aureus (99%) 
2945  Staphylococcus aureus  Staphylococcus aureus (100%) 
2362  MRSA  Staphylococcus aureus (94%) 
3059*  MRSA  Staphylococcus aureus (92%) 
3361  MRSA  Staphylococcus aureus (99%), 
Corynebacterium sp, (95%) 
Streptococcus agalactiae (99%) 
67*  MRSA  Staphylococcus aureus (98%), 
Enterobacter sp. (96%)  
2920  Staphylococcus sp.  Staphylococcus simulans (96%), 
Corynebacterium sp. (97%) 
65  Staphylococcus sp.  Corynebacterium sp. (96%) 
127B  Pseudomonas aeruginosa  Clostridium sp. (100%) 
117B*  Staphylococcus aureus  Negative  
131C*  Staphylococcus sp.  Negative  
107  MRSA  Negative  
127A  Pseudomonas aeruginosa  Negative  
131D*  Staphylococcus sp.  Negative  
1216*  MRSA  Negative  
112  MRSA, Serratia marscesens, 
Enterococcus sp.  
Staphylococcus aureus (95%), 
Serratia sp.  (99%)  
97  Proteus mirabilis, 
Corynebacterium,  
Staphylococcus sp.  
 Proteus mirabilis (94%), 
Clostridium sp. (98%), 
Porphyromonas somerae (94%)  
797*  Streptococcus sp., 
Staphylococcus aureus, 
Staphylococcus sp., 
Corynebacterium  
Streptococcus pneumonia 
(98%), Candidatus peptoniphilus 
massiliensis (96%) 
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Tissue 
Number  
Culture Results  16S PCR-DGGE Results  
864   Group B Streptococcus, Gamma 
Streptococcus Corynebacterium, 
Staphylococcus sp., Prevotella  sp.  
Streptococcus agalactiae (97%), 
Enterococcus faecalis (97%), 
Enterobacter (93%)   
101  Beta Hemolytic Streptococcus , 
Pseudomonas aeruginosa , Acinetobacter 
baumanii, MRSA  
Streptococcus dysagalactiae (99%), 
Corynebacterium (97%) 
108 *  Corynebacterium, Staphylococcus aureus, 
Group B Streptococcus  
Corynebacterium sp. (99%), 
Actinobacterium sp. (92%) 
113*  Pseudomonas aeruginosa, Enterobacter 
cloacae, Staphylococcus sp.  
Pseudomonas aeruginosa (96%)  
1044  Pseudomonas aeruginosa, Enterococcus, 
Citrobacter freundii  
Pseudomonas aeruginosa (100%) 
2669  Streptococcus sp., Pseudomonas 
aeruginosa, Staphylococcus  sp.  
Streptococcus anginosus (99%) 
1025  Enterococcus sp., Enterobacter 
aerogenes, E. coli, Prevotella, 
Pseudomonas aeruginosa, Gamma 
Hemolytic  
Enterococcus faecalis (99%) 
2085  Enterococcus sp., Prevotella sp.  Enterococcus faecalis (99%) 
2986  Corynebacterium sp., Pseudomonas 
aeruginosa,  
Corynebacterium sp. (90%) 
94B*  
   
Gram neg. rods, lactose fermenters, 
Achromobacter  
Pseudomonas aeruginosa (96%) 
104*  MRSA, Staphylococcus sp., 
Corynebacterium  
Negative  
104B*  MRSA, Staphylococcus sp. 
Corynebacterium sp.  
Negative  
 
 
Table 3: Culture positive tissue samples. Eighteen out of the 50 tissue samples 
were monomicrobial. Fifteen out of the 50 tissue samples were polymicrobial. Red = 
congruency. Anaerobes are underlined. Tissue numbers with an asterisk (*) indicate 
that Geobacillus sp. were identified in the sample by the molecular method. 
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medical settings for sterilization of medical instrumentations and medical waste  
(26).  Geobacillus has not been found to cause human infection, however, it was 
present in 12 of the 50 tissue samples. It is possible that the molecular method is 
detecting DNA from the Geobacillus spores left in the autoclaves after the validation 
of sterilization testing that have contaminated the autoclaved medical instruments 
used for the biopsies in this study.  
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DISCUSSION 
The overall goal of this project was to use PCR amplification of a portion of 
the 16S rRNA gene to test an alternative approach for the identification of the 
causative agents in musculoskeletal infections and to assess the diversity of the 
bacteria involved. The advantages of this alternative method are that it should 
increase sample sensitivity and the speed of detection. In addition, bacteria that are 
non-culturable or in low abundance can be detected using a molecular method. The 
16S rDNA PCR-DGGE method, applied many molecular techniques, which included 
several critical steps: DNA extraction from biopsied tissue, amplification of the 
bacterial DNA by PCR, PCR product separation by DGGE, extraction and re-
amplification of the DNA from the gel slices, and DNA sequencing and analysis. 
The first goal of this project was to optimize each step of the protocol so that 
it was sensitive and rapid as possible. The first step in the protocol to be optimized 
was the DNA isolation. The DNA isolation protocol required two days to complete. 
Several steps were modified to increase sensitivity. These steps included the 
addition of lysostaphin for the efficient lysis of S. aureus cells. Without the addition 
of lysostaphin the detection of S. aureus cells was greatly diminished. This is 
important because S. aureus is one of the most common pathogens in 
musculoskeletal infections. Our results confirmed this to be the case in our 50 
samples, as S. aureus was identified in ten samples by the molecular approach and 
in 11 by culture.  
 Another factor that was important in the DNA isolation step was the 
prevention of contamination. Contamination was a problem in the beginning of this 
study. The use of disposable tissue grinders and UV light treatment of cell lysis 
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solution, sterile water and instruments before DNA isolation was crucial to prevent 
contamination.  The use of EMA to eliminate DNA contamination of the reagents 
was also important. 
The second step of the molecular method was PCR amplification of the 16S 
rRNA gene. The choice of primers for the PCR amplification was important. The 
goal of the molecular method was to identify all possible bacterial causative agents 
in musculoskeletal infections.  To accomplish this goal, the primers must be able to 
hybridize to the conserved regions of the 16S rRNA gene. It was also important that 
the variable regions amplified contained enough unique information content to 
ensure that an identification of the species could be made. The choice of which 
variable region to amplify was based on the comparison of 123 16S rRNA gene 
sequences of the most common pathogens in musculoskeletal infections. This 
sequence comparison determined that variable region V3 and V4 would be the best 
choice for this study because it would speciate almost all of the possible bacterial 
organisms. 
The third step in this method involves the use of DGGE to separate the 16S 
rDNA PCR products present in polymicrobial samples. This technique has not been 
widely used for medical diagnostic purposes. This molecular technique was 
essential for the overall success of the identification of organisms in the molecular 
method. Without this technique 15 out of the 50 tissue samples would not have 
provided readable DNA sequences for identification. The DGGE protocol has 
several components that are important for DNA electrophoresis and visualization. 
The method of pouring of the acrylamide solution was critical to ensure uniform 
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movement and arrest of the PCR products. The Bio-Rad DCode system included a 
calibrated wheel that was used. This was not an ideal method to use to prepare 
generate the gradient gels. It was time consuming to setup and the gradient was 
less consistent then the one obtained with a gravity gradient maker. The latter was 
used for the analysis of the 50 tissue samples in this study.  
The acrylamide and denaturing solution concentrations were critical to the 
optimized migration of the PCR products. Several concentrations of both acrylamide 
and denaturants were tested, but the best separation observed between the PCR 
products was seen with a double gradient gel of acrylamide and denaturant. The 
visualization of the DGGE gel bands also was a problem in the beginning of this 
project. However, after performing experiments in which various amounts of DNA 
were electrophoresed through the DGGE gel, it was determined that there was a 
balance between over loading the gel, which produced smears, and loading too 
little, which could hardly be seen. In addition, the use of GelRed to stain the DGGE 
gel proved to be very useful. GelRed does not require a destaining step and is non-
toxic, which is helpful when staining a large gel. 
Several methods for DNA extraction from DGGE bands were explored. One 
method was extraction of DNA using the QIAquick gel extraction kit (Qiagen) 
modified for acrylamide gels based on the manufacturer’s recommendations. This 
method gave very poor recovery of the DNA. About half of the DNA loaded into the 
gel was lost. Secondly, a small piece of gel slice was placed directly into the PCR 
tube to serve as the DNA template in a PCR reaction. This method only worked for 
a few DGGE slices. It was not very consistent in producing a PCR product .Thirdly, 
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the gel slice was cut into pieces and placed in a centrifuge tube with water and left 
overnight. The DNA would then diffuse into the water, which served as the template 
for PCR. This method was consistent and most DGGE slices gave a strong PCR 
product. However, the question of whether all of the DNA was being released into 
the water remained. The fourth method involved shredding the gel slice by bead 
beating and leaving it overnight at 4°C. This method produced the most successful 
template and all of the DNA present was most likely being released into the solution 
to be used as a template for PCR amplification. 
The sequencing and analysis of the DNA from the DGGE slices was the final 
step in the molecular method. To obtain an optimal DNA sequence with no 
background signal, it was important that primer dimers were not present in the 
sequencing template. The use of linker primers was critical to the success of this 
project because it allowed a DNA sequence of the entire PCR product to be 
obtained (31). This was important because the PCR product size was not very large 
(360 bp) and all the PCR product DNA sequence was needed to identify the species 
with confidence.   
The second goal of this study was to use the optimized 16S rDNA PCR-
DGGE method to analyze 50 tissue biopsy samples chosen randomly from our 
collection. The molecular method was congruent for ten of the 17 (59%) culture 
negative tissue samples. In seven of the 17 (41%) culture negative samples the 
molecular method identified a bacterium. The molecular method was congruent with 
the culture identification for seven of the 33 (21%) positive cultured tissue samples. 
However, in eight of the 33 (24%) the molecular method identified more organisms. 
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In 13 of the 15 (87%) polymicrobial cultured tissue samples the molecular method 
identified at least one organism that was also identified by culture techniques.  
Forty-seven out of the 50 (94%) tissue samples had anaerobic cultures 
performed. Within those 47 tissue samples the molecular method found two tissue 
samples to contain strict bacterial anaerobes that were not detect by culture 
analysis. In one of the three tissue samples that did not have an anaerobic culture 
performed, the molecular method found two strict anaerobe bacterial species. Even 
though for the majority of the cases anaerobic cultures were taken the molecular 
method was still able to identified additional strict anaerobes. 
Eight tissue samples (1921, 2764, 93, 3514, 797, 65, 103, 864) in the 50 
were collected when the patient was already on antibiotics. Specifically, for tissue 
#1921 which was negative culture, samples were taken from a patient with a 
positive culture of MRSA four days earlier, which may indicate that the antibiotic 
was eradicating the infection but the molecular method was still able to detect 
Staphylococcus aureus cells.  
Another interesting case is tissue # 2764 which was found to be culture 
negative, but had two cultures performed 12 and 14 weeks later. At 12 weeks the 
culture analysis identified MRSA and Acinetobacter. At 14 weeks later the culture 
analysis identified Acinetobacter, Group B Streptococcus, and Corynebacterium. 
The molecular method was able to detect the Streptococcus sp. much earlier than 
the culture method. Tissues #93 and #3514 were culture negative and had no 
further evidence of infection after the course of antibiotics.  Tissues #797, #65, 
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#103, and #864 were found culture positive even though the patient was on 
antibiotics at the time of tissue biopsy.  
The differences in identification between the two methods could be due to 
many reasons. The first and simplest reason is that each tissue sample tested by 
the molecular method was not exactly the same as the sample that was used for the 
culture method. All of the tissue samples used for the 16S rDNA PCR method were 
the discarded tissue from the Medical Microbiology Lab and may not be a true 
representative of the original tissue sample that was tested in their laboratory.  This 
potential problem could be resolved if the IRB protocol was modified to allow that 
the biopsied tissue be mixed and split between the clinical laboratory and the 
research laboratory immediately after the collection.  
The second reason for a discrepancy between the culture and the molecular 
results could be that the DNA extraction, PCR, or DGGE do not represent all 
bacterial species in the tissue samples. Some kind of bias could be occurring in the 
PCR amplification step of the molecular method. The experiment in which the PCR 
amplification of three different templates in one reaction was performed seemed to 
indicate that some PCR amplification bias may be occurring during this step. When 
a low concentration of E. faecalis was added into a PCR amplification reaction with 
templates that were 10 x and 100x more concentrated, it was difficult to observe the 
E. faecalis PCR product in the DGGE gel. This PCR reaction represents the worst 
case scenario that could possibly occur, which is having a DNA species that 
represents only 1% of the DNA template.  A bias in amplification of rare DNA 
species is also supported by the fact that most species missed by the molecular 
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method were usually noted as being rare or few in the culture results. This is the 
case in tissue # 97; the molecular method detected Proteus mirabilis as the most 
predominant bacterial species, but did not detect Corynebacterium and 
Staphylococcus sp. which were described as ‘rare’ and ‘few’ respectively. A 
possible solution for this problem could be using different conserved primers that 
may be more efficient in amplification of the low percentage DNA species in a mixed 
template PCR reaction. A second possible solution is performing a multiplex PCR 
reaction which uses multiple primers in one PCR reaction. This type of PCR 
amplification could be better in amplifying low percentage DNA species. A third 
possible solution is to change the molecular method protocol of the second PCR 
amplification step which adds the high GC region at the 5’ end, to use the 
chromosomal DNA as template for the PCR reaction instead of the initial PCR 
product as template. It is possible that a nested PCR reaction may not be very 
efficient in amplifying rare DNA species and that returning to the chromosomal DNA 
would be more efficient. The mixed template PCR amplification experiment may 
indicate that an amplification bias against low percentage DNA species may exist. 
However, additional experiment s should be done to understand this amplification 
bias thoroughly. 
A less likely reason for differences in identification between the two methods 
could be insufficient separation between the PCR products of similar DNA species. 
Some DNA species such as Pseudomonas and Staphylococcus aureus seem to 
arrest their migration through the DGGE gel in very similar positions. Pseudomonas 
and S. aureus were not found together by the molecular method, but they were 
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identified together in one tissue sample by culture analysis. In cases where very 
similar DNA PCR products or PCR products that migrate to a similar location in the 
gel are present, a smaller DGGE gradient can be used to improve the separation. 
Specifically to create greater separation between Pseudomonas and S. aureus a 
45-60% denaturing solution gradient should be used. However, for most cases the 
DGGE of the PCR products were found consistently in the same location. Almost all 
bacterial species were consistently found is similar positions in the DGGE gel. 
Some tissue samples were done multiple times at different time and consistently 
showed the same pattern of DGGE DNA banding.   
Overall, the DGGE analysis of 16S rDNA seems to be an alternative method 
to identify bacteria not identified by culture analysis. This method does have 
limitations for the identification of pathogens. The method requires specific 
instrumentation and a person trained in these molecular techniques in order to be 
successful. It relies on efficient amplification of all DNA species present and correct 
separation of the PCR products in the DGGE gel, which has not been definitely 
proven by this method.  As a result this method may not be ideal for use in the 
clinical microbiology laboratory for the general identification of pathogens. However, 
in cases were no pathogen is cultured and the patient is not recovering with the 
prescribed antibiotics, this method may provide some information that can aid in the 
patient’s recovery.  
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PERSPECTIVES 
Several molecular techniques for bacterial identification have been 
investigated by others in the field. These molecular techniques include antigen 
recognition (43), PCR amplification of genes that are specific to the suspected 
organism (14), microarrays (20), and 16S PCR amplification (40).  However, these 
investigations usually examine a small number of samples and do not compare the 
molecular results to that of patient culture results. The goal of this project was to 
develop a rapid, sensitive and unbiased molecular method to identify all possible 
pathogens directly from infected tissue samples, without the need for culture. PCR 
amplification of the 16S rRNA gene has been widely used because of the ability to 
amplify thousands of possible bacteria present in the sample. After the PCR 
amplification, sequence analysis is usually performed in order to identify the 
organism. If several distinct PCR sequences are present in the PCR product direct 
sequencing is not reliable.  New sequencing technology may solve this problem. 
Pyrosequencing is able to sequence multiple templates. However, currently this 
technology is still expensive for mass clinical use as a method of pathogen 
identification. In addition, pyrosequencing is limited to sequencing DNAs about 400 
bp. If improvements are made in pyrosequencing or other types of single strand 
sequencing methods and the cost of analysis is reduced this may be a good option 
for pathogen identification.   
Another molecular technique that may be a good option for rapid 
identification of pathogens is mass spectrometry. This molecular technique is very 
rapid and is becoming more commonly used. However, accurate identification of all 
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species in polymicrobial infections using mass spectrometry is still under 
discussion. Also a reference spectrum is required to obtain a definite identification 
of the pathogen. At this point the database of reference spectrums is limited, but it is 
growing rapidly. In the future this molecular technique may also be a suitable option 
for molecular identification of all pathogens not just bacterial. 
In the present time however a microarray may be the best option for a 
molecular method to identify pathogens. The price of a microarray has decreased 
and has become widely used and easier to construct. A tiled microarray of portions 
of the entire 16S rRNA genes of hundreds of bacterial pathogens could be a rapid 
and more standardized method for the identification of pathogens. Practically, 
several different microarrays could be constructed, for the purposes of this study a 
microarray with the most common and hard to culture musculoskeletal bacterial 
pathogens would be used. However, if needed a microarray could be constructed 
with pathogens associated with meningitis, cardiovascular infections or other types 
of infections.  
This investigation chose to develop a 16S rRNA gene PCR amplification 
method for the identification of bacteria. To solve the problem of resolving mixed 
DNA sequences in a PCR product, we chose to use a denaturing gradient gel 
electrophoresis. This molecular technique separates DNA molecules into individual 
species. DGGE has been used for monitoring bacterial populations in environmental 
samples and has not been used extensively for pathogen identification. The use of 
DGGE seemed promising as a rapid method for separating bacterial 16S rRNA 
gene PCR products for sequence analysis. However, much like other 16S rRNA 
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gene methods, the 16S rRNA gene PCR-DGGE method had problems. The results 
of this study indicate that this method as currently optimized is not able to identify all 
possible pathogens in a tissue sample.  This molecular method may serve best to 
identify pathogens in tissue samples that are culture negative.  
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